STRATA Skin Sciences to Participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1×1 Conference
HORSHAM, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical...
News
Vitaquest International Joins International Probiotics Association to Help Drive Probiotic Innovation
As members, Vitaquest will work to influence and communicate existing regulations to address industry challengesWest Caldwell, New Jersey--(Newsfile Corp. -...
NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company...
Healing Realty Trust Announces Preferred Real Estate Partnership Agreements with NeuroSpa, Cambridge Biotherapies and Cathexis to Enhance Clinic-Focused Portfolio
Jupiter, Florida--(Newsfile Corp. - August 6, 2024) - Healing Realty Trust ("HRT" or the "Company"), a data-driven, self-managed real estate...
InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
- Announced positive outcomes from the C-GUARDIANS IDE clinical trial of the CGuard™ Prime carotid stent system demonstrating a one-year...
Bemax Inc. Signs Letter of Intent to Acquire Kona Gold, LLC
Strategic Acquisition to Strengthen Bemax's Consumer Packaged Goods Portfolio and Drive Market GrowthDallas, Georgia--(Newsfile Corp. - August 6, 2024) -...
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio’s Patented INTASYL Compound
Phio's INTASYL compound targets aging skin disordersMarlborough, Massachusetts--(Newsfile Corp. - August 6, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a...
TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose...
Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders’ Equity Remains Near Record Highs at $36M, or $2.25 per Share
CHICAGO, IL / ACCESSWIRE / August 6, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
Figure 1 Combination of dulaglutide (Trulicity®) and buntanetap improves memory and synaptic plasticity in AD mice (*p<0.05, **p<0.01). Figure 2...
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
19,000-square-foot facility reflects the company’s recent growth and continued commitment to the regionMORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) --...
Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
Clinical update presented at ASCO 2024 for CRB-701 showed continued differentiated safety and encouraging efficacy in patients with metastatic urothelial...
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
SUMMIT, PEAK and APEX registration-directed clinical trial enrollment remains on track; topline results expected from all three studies in 2025...
Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan
A$4.4 million of valid applications received for the Share Purchase PlanIn conjunction with recently completed A$8.0 million institutional placement, total...
COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference
LONDON, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access...
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today...
Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer
Oak Ridge, TN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...
Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in...
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
NASHUA, N.H., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer...